Retrospective study assessing the efficacy of gefitinib treatment in patients with advanced adenocarcinoma of the lung

Trial Profile

Retrospective study assessing the efficacy of gefitinib treatment in patients with advanced adenocarcinoma of the lung

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Feb 2016

At a glance

  • Drugs Gefitinib (Primary)
  • Indications Adenocarcinoma; Lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top